Did you know that tailored lighting interventions can help reduce fatigue and improve wellbeing in patients with cancer? Find out why: hubs.la/Q03m0gt60 #MedicalResearch #CancerCare

What are the most promising strategies to overcome treatment resistance in genitourinary cancers? Find out in the latest episode of Onc Now, where Jonathan Sackier sits down with Joan Carles, Vall d’Hebron University Hospital. Tune in here: hubs.la/Q03msD6P0

Could exercise help close the survival gap in colon cancer? Find out: hubs.la/Q03nYN7g0

What's new from ESGO 2025? Find out in the latest episode of Onc Now, where Jonathan sits down with Bradley Monk, Florida Cancer Specialists, to discuss updated endometrial cancer guidelines, new trial results and much more. Tune in here: hubs.la/Q03prlDN0

"A good doctor, a doctor of the future, is one who can understand what the NHS can do right now and envisage the 5–10 years of a patient’s journey." Uncover more of Dr Lennard Lee (Oxford University), University of Oxford's insights on the future of healthcare in his full interview: hubs.la/Q03rq2Qx0

Want to learn how to stay innovating in oncology? Tune in to this week's episode of Onc Now, where Bradley Monk returns to share key understandings from SGO 2025, alongside a fascinating deep dive into drug approval and access in the field. Tune in: hubs.la/Q03rQl5P0

A major US study shows managing midlife chronic conditions can play a key role in reducing future cancer risk and mortality. Find out more: hubs.la/Q03spBBc0

How could cancer vaccines change the future of oncology? Find out in this episode of Onc Now, where Dr Lennard Lee (Oxford University), Associate Professor of Cancer Vaccines at the University of Oxford, explores initiatives bringing fresh innovations to patients. Tune in: hubs.la/Q03tyWLV0

Breast MRIs just got smarter. AI now helps detect hidden aneurysms before they become a deadly threat. Find out more: hubs.la/Q03v1-5V0

Want to discover more of Lennard Lee, University of Oxford's insights on the cancer vaccine revolution? Read his full interview from our latest Summer journal: hubs.la/Q03vB7Ps0

A trial shows a new drug combination for advanced soft tissue sarcomas can boost immune cell activation in these challenging "cold" tumours. Read full article: hubs.la/Q03w26Ph0

New research reveals how melanoma can start from a single genetic change, offering clues to early skin cancer development. Find out more: hubs.la/Q03wQnCN0

How are precision medicine and trials reshaping breast cancer care in the UK? Find out in this episode of Onc Now, in which Jean Abraham explores the promise of personalised cancer vaccines, the power of data science and AI in cancer care, and more. 🔗: hubs.la/Q03xVHg50

Delayed breast cancer surgery significantly increases mortality risk, especially for HR+/HER2− subtypes. Find out more from the study here: hubs.la/Q03y0RFB0

Did you know that thousands of people with HIV are missing out on life-saving cancer treatment? Find out more: hubs.la/Q03y0SmL0

New study finds patients with both lung cancer and rheumatoid arthritis can receive immunotherapy without compromising survival. Find out more: hubs.la/Q03zfCCQ0

Can metabolic insights redefine breast cancer care? Find out in this latest episode of Onc Now, where Professor Simon Lord, University of Oxford, brings a translational lens to the bench-to-bedside journey. hubs.la/Q03Bxy-D0

Could a combination of light therapy and anti-inflammatory cream be the answer for stubborn skin redness? Learn more: hubs.la/Q03CMFB00

A new dataset from Germany could transform how we understand and treat head and neck cancer, offering new hope for precision medicine. Uncover insights from the HANCOCK study: hubs.la/Q03CTYy70